EPISODE · Oct 26, 2022 · 22 MIN
Ep4: Part3: Conversation with Charley Hooper
from DC EKG
In part three of this discussion with Charley Hooper, FDA expert and former NASA official, they examine the legacy of FDA’s its “white hat” reputation and how it’s not as deserved as it once was. In addition, they discuss the chilling effect new legislation will have on new cancer treatments, as well as the punitive effect this will have on generic drugs, patients in need of drugs for rare disorders, and testing already approved drugs to combat other diseases.
NOW PLAYING
Ep4: Part3: Conversation with Charley Hooper
No transcript for this episode yet
Similar Episodes
Jul 16, 2026 ·13m
Jul 15, 2026 ·11m
Jul 14, 2026 ·17m
Jun 25, 2026 ·76m
Jun 24, 2026 ·73m